Invo Fertility Inc.

01/13/2026 | Press release | Distributed by Public on 01/13/2026 19:03

Initial Statement of Beneficial Ownership (Form 3)

FORM 3
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden hours per response... 0.5
(Print or Type Responses)
1. Name and Address of Reporting Person *
Krigsvold Terah Renee
2. Date of Event Requiring Statement (Month/Day/Year)
12/30/2025
3. Issuer Name and Ticker or Trading Symbol
INVO Fertility, Inc. [IVF]
(Last) (First) (Middle)
C/O INVO FERTILITY, INC., 5582 BROADCAST COURT
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Chief Financial Officer
5. If Amendment, Date Original Filed (Month/Day/Year)
(Street)
SARASOTA, FL 34240
6. Individual or Joint/Group Filing (Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 1 D
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(Month/Day/Year)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) (1) 01/03/2031 Common Stock 3 $17,683.2 D
Stock Option (right to buy) (2) 02/10/2032 Common Stock 3 $17,280 D
Stock Option (right to buy) 12/29/2022 12/28/2032 Common Stock 2 $2,304 D
Stock Option (right to buy) 01/13/2023 01/12/2033 Common Stock 2 $2,983.68 D
Stock Option (right to buy) 01/31/2023 01/30/2033 Common Stock 2 $3,882.24 D
Stock Option (right to buy) (3) 05/17/2033 Common Stock 11 $2,119.68 D
Stock Option (right to buy) (4) 08/25/2035 Common Stock 4,375 $8.96 D

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Krigsvold Terah Renee
C/O INVO FERTILITY, INC.
5582 BROADCAST COURT
SARASOTA, FL 34240
Chief Financial Officer

Signatures

/s/ Terah Krigsvold 01/13/2026
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) The option vested in monthly increments over a period of 36 months from January 1, 2021.
(2) The option vested in monthly increments over a period of 36 months from February 11, 2022.
(3) The option vests in 12 equal installments beginning on May 18, 2023 and on the last day of each calendar quarter thereafter until fully vested.
(4) The option vests in four equal installments beginning on the first day of the calendar quarter following August 26, 2025 and on the first day of each calendar quarter thereafter until fully vested.
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.
Invo Fertility Inc. published this content on January 13, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on January 14, 2026 at 01:04 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]